Journal
NANOSCALE
Volume 7, Issue 6, Pages 2336-2351Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4nr04426f
Keywords
-
Categories
Funding
- European project Magnifyco [NMP4-SL-2009-228622]
- Italian AIRC [14527]
- EU-ITN network Mag(net)icFun [PITN-GA-2012-290248]
- Italian FIRB [588 BAP115AYN]
Ask authors/readers for more resources
Efficient targeting in tumor therapies is still an open issue: systemic biodistribution and poor specific accumulation of drugs weaken efficacy of treatments. Engineered nanoparticles are expected to bring benefits by allowing specific delivery of drug to the tumor or acting themselves as localized therapeutic agents. In this study we have targeted epithelial ovarian cancer with inorganic nanoparticles conjugated to a human antibody fragment against the folate receptor over-expressed on cancer cells. The conjugation approach is generally applicable. Indeed several types of nanoparticles (either magnetic or fluorescent) were engineered with the fragment, and their biological activity was preserved as demonstrated by biochemical methods in vitro. In vivo studies with mice bearing orthotopic and subcutaneous tumors were performed. Elemental and histological analyses showed that the conjugated magnetic nanoparticles accumulated specifically and were retained at tumor sites longer than the non-conjugated nanoparticles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available